Voyageur Pharmaceuticals secures $1 million on first Bayer milestone
Voyageur Pharmaceuticals Ltd. said it achieved its first milestone under a non-dilutive Bayer collaboration, securing a $1 million payment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.